Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Cancer

Explore clinical trials studying Gastrointestinal Cancer. Study availability and eligibility vary by location and protocol.

167 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Cancer trial results

Completed

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

NCT05001347

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +36 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
View all 15 locations
View Trial Details
Completed

Improving Cancer On-treatment Symptom Management

NCT04589247

Conditions
Cancer, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Bayview Medical Center Baltimore, Maryland, United States
  • Khinh Voong Baltimore, Maryland, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details
Completed

Symptom Management Implementation of Patient Reported Outcomes in Oncology

NCT03850912

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +7 more
Locations
  • Maine Medical Center Portland, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Brown University Health (formerly Lifespan Cancer Institute) Providence, Rhode Island, United States
View Trial Details
Completed

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

NCT04736472

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +4 more
Locations
  • Lancaster General Hospital Lancaster, Pennsylvania, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

NCT03597581

Conditions
CRC, Colonic Diseases, Colorectal Cancer, +18 more
Locations
  • Arizona Oncology Associates, PC - HAL Prescott Valley, Arizona, United States
  • Arizona Oncology Associates, PC - HOP E Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Sharp HealthCare San Diego, California, United States
View all 17 locations
View Trial Details

Related conditions